ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

National Cancer Institute (NCI) 

NCI Public Inquiries Office
Building, 31, Room 10A03
31 Center Drive, MSC 2

Bethesda  Maryland  20892-2580  U.S.A.
Phone: 301-435-3848 Fax:


SEARCH JOBS




Collaborations

Maxygen, Inc. 

Genzyme General 

PanVera LLC 

Panacos Pharmaceuticals Inc.  Panacos has a CRADA with leading scientists at the National Cancer Institute to study the mechanism of HIV maturation inhibitors and to discover new antiviral drugs.





 Company News
Agenus (Formerly known as Antigenics Inc. - Lexington, MA) (AGEN) Announces Initiation of Enrollment in National Cancer Institute-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors 5/22/2013 9:56:12 AM    More...
Eating Candy Will Not Make You Fat, National Cancer Institute Study 5/21/2013 7:29:56 AM    More...
ApoCell, Inc. Announces Delivery of First Prototypes of ApoStream™ Circulating Tumor Cell (CTC) Isolation Technology to National Cancer Institute 5/16/2013 9:14:32 AM    More...
Promising Results in Treating a Lymphoma in Young People, National Cancer Institute Study 4/17/2013 7:07:38 AM    More...
Tekmira Pharmaceuticals Corporation's Collaborators at the National Cancer Institute Present Preclinical Data at the Annual Meeting of the American Association for Cancer Research (AACR) 4/10/2013 11:23:04 AM    More...
Insight Genetics and National Cancer Institute Collaborate to Develop New Technologies for Clinical Trials 4/1/2013 3:15:34 PM    More...
Presentation of Collaborative Research by the National Cancer Institute, University of California, San Francisco (UCSF)-Helen Diller Comprehensive Cancer Center and BioScale, Inc. Researchers at the 2013 American Association for Cancer Research Meeting 3/5/2013 9:35:32 AM    More...
Discovery of New Class of Damage-Prone DNA Regions Could Lead to Better Cancer Treatments, National Cancer Institute Study 1/25/2013 7:36:24 AM    More...
Epic Sciences Awarded a Phase II SBIR Contract From National Cancer Institute/National Institutes of Health (NIH) to Develop a Lung Cancer Diagnostic Blood Test 1/24/2013 9:41:13 AM    More...
National Cancer Institute Team Discovers New Gene That Affects Clearance of Hepatitis C Virus 1/8/2013 7:54:27 AM    More...
12345678910...